Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
In the air-conditioned haven of the Hilton just downriver from the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, Mike Doustdar spoke with a quiet confidence and a smile a | Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company.

Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…

For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first oral…

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

Mike Doustdar setzt alles daran, den Konzern im Rennen gegen US-Rivalen Eli Lilly wieder nach vorn zu bringen. Ein Mann mit einer…

CNBC's Charlotte Reed will travel to Copenhagen to speak with Novo Nordisk's new CEO after a bumpy few months.